Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Overview Trevena Inc. (Nasdaq: TRVN) is set to present tomorrow February 12 at 9:15 EST at the 21st Annual BIO CEO & … [Read more...] about TRVN to Present at BIO & CEO Conference
Search Results for: Trvn
Introduction Trevena Inc. (Nasdaq: TRVN) spiked 119% from the $.5 range to $1.19 on January 28th. The catalyst being positive regulatory updates from the FDA Type A meeting minutes. In a nut-shell the … [Read more...] about 2019 Should Be A Good Year For TRVN, But What’s Next?
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Good Morning! We hope you all are enjoying your early morning trading! Today, three companies we … [Read more...] about Morning Update-Form 13G’s On Deck!
Overview Swing Trading is a trading strategy that involves buying a stock at lower price and selling it at a higher price over a short period of time. Return on investment targets range from … [Read more...] about Swing Trading a Biotech Stock
Premarket today TRVN has dropped almost 70% off news that the FDA believes their drug Oliceridine has high abuse potential. With ACRX's ADCOM this week too I can understand the hesitation to … [Read more...] about ACRX Stay the course
Question by deadpool from StockTwits: Q: "how do you feel about ACRX price action today seems like just a red market is tearing everything down. i am hopeful we get back up to 3.30s next week" Thanks … [Read more...] about A Question about ACRX price decline after Dsuvia approval
AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) Swing Thesis ACRX traded last around $2.90 and has entered oversold territory. It has a FDA advisory committee meeting (ADCOM) scheduled for 10/12/2018 and a … [Read more...] about SWING ALERT
Introduction Recro Pharma (NASDAQ: REPH) engages in the research and development of non-opioid therapeutics for the treatment of acute postoperative pain. REPH is currently developing three … [Read more...] about $REPH – Recro Pharma, PDUFA Swing Trade
ArticleEquityEntry PricePeak PriceGain/Loss12/31/20188/17/18GALT$3.80$6.98 (9/20/18)+84%$3.438/27/18ADMP$2.80$4.25 (9/26/18)+52%$.2.259/14/18 TRVN$1.65$3.58 … [Read more...] about Performance Record 2018
Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and earnings all on offer. Biogen Inc (NASDAQ: BIIB) announced an $800-million deal to buy … [Read more...] about The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs